KCUC Introduces MRI Fusion Technology for More Effective Prostate Biopsies

March 12, 2015 — Overland Park, KS — Kansas City Urology Care is pleased to announce the addition of MRI Fusion technology as part of its comprehensive line of men’s health services, procedures and solutions.  This new technology will dramatically change the way prostate cancer is tested and managed for Kansas City-area men of all ages.


Approved by the FDA, this technology combines ultrasound with MRI of the prostate.  The fusion of these images allows KC Urology Care providers to more accurately target biopsies for better patient outcomes.  By overlaying real-time ultrasound images with areas of interest identified by the MRI, the urologist is better able to target the mass for biopsy, and ultimately, diagnose and be more precise in finding the more aggressive cancers.

Studies show that “30% more high-risk prostate cancers were diagnosed with targeted fusion-guided biopsy than with standard biopsy.  In addition, 17% fewer low-risk cancers were diagnosed with the fusion-guided approach” (JAMA 2015; 313:390-7).

KC Urology Care is the first urological care provider in Kansas City to bring this technology to the region.

A targeted prostate biopsy using MRI Fusion technology is just one of the many safe procedures KC Urology is able to offer.  With a comprehensive staff of 23 urologists, three radiation oncologists, a pathologist and five non-physician providers combined with state-of-the-art equipment and modern facilities gives KC Urology the ability to offer several minimally invasive treatments, from endoscopic procedures to microwave therapy to, of course, prostate cancer screening and diagnosing.

Click here to learn more about prostate cancer and how KC Urology Care diagnoses and treats the disease.

KCUC First With REZUM®

View Rezūm Patient Education from REZUM on Vimeo.

Kansas City Urology Care is the first practice in Kansas City to offer NxThera’s REZUM® treatment for BPH. REZUM uses radio-frequency (RF) energy to create sterile water vapor to delivery targeted, precise thermal energy treatments in a simple, office-based setting with minimal discomfort. REZUM was FDA cleared in August of 2015.

Schedule an appointment today and ask a KCUC urologist about this therapy.

American College of Radiology Radiation Oncology Accredited Facility
Accredited by the premier credentialing body for radiation oncology, ACR (The American College of Radiology).